請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71998
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 孫璐西(Lucy Sun Huang) | |
dc.contributor.author | Lan-Hsin Hung | en |
dc.contributor.author | 洪蘭欣 | zh_TW |
dc.date.accessioned | 2021-06-17T06:18:25Z | - |
dc.date.available | 2019-08-24 | |
dc.date.copyright | 2018-08-24 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-20 | |
dc.identifier.citation | 內政部統計處(2017)。2016年內政統計通報,臺北:內政部統計處。
內政部戶政司(2018)。2016年內政統計通報,臺北:內政部統計處。 洪永瀚:苜蓿芽乙酸乙酯萃取物對發炎反應與自體免疫鼠病程的影響。國立臺灣大學微生物與生化學研究所博士學位論文,2008.207p。 Akaogi, J., T. Barker, Y. Kuroda, D. C. Nacionales, Y. Yamasaki, B. R. Stevens, W. H. Reeves, and M. Satoh. 2006. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev. 5(6): pp.429-435. http://dx.doi.org/10.1016/j.autrev.2005.12.004 Arnett, F. C., S. M. Edworthy, D.A. Bloch, D. J. McShane, J. F. Fries, N.S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra.1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 31: 315-24. Aschermann, S. et al. 2010. The other side of immunoglobulin G: Suppressor of inflammation. Clinical and Experimental Immunology. Wiley/Blackwell (10.1111), 160(2), pp. 161–167. doi: 10.1111/j.1365-2249.2009.04081.x. Avouac, J., L. Gossec, and M. Dougados. 2006. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 65: 845-51. Bläss, S. , J. M. Engel, and G. R. Burmester. 1999. The immunological homunculus in rheumatoid arthritis. Arth Rheum. 42: 2499-506. Bajtner, E., K. S. Nandakumar, A. Engström, and R. Holmdahl. 2005.Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arth Res Ther. 7: 1148-57. http://dx.doi.org/10.1186/ar1800 Bendele, A. 2001. Animal models of rheumatoid arthritis. J Musculoskel Neuron Interact. 1: 377-85. Bendele, A., J. McComb, T. Gould, T. McAbee, G. Sennello, E. Chlipala, and M. Guy. 1999. Animal models of arthritis: Relevance to human disease. Toxicol Pathol. 27: 134-42. http://dx.doi.org/ 10.1177/019262339902700125 Bonnotte, B., M. Gough, V. Phan, A. Ahmed, H. Chong, F. Martin, and R. G. Vile. 2003. Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells. Cancer Res. 63: 2145-49. Bornstein, P., and H. Sage. 1980. Structurally distinct collagen types. Ann Rev Biochem. 49: 957-1003. http://dx.doi.org/10.1146/annurev.bi. 49.070180.004521 Brand, D. D., K. A. Latham, and E. F. Rosloniec. 2007. Collagen-induced arthritis. Nat Protoc. 2: 1269-75. http://dx.doi.org/10.1038/nprot.2007.173 Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 2: 244-7. Cheng, W. Y., Y. H. Kuo, and C. J. Huang. 2007. Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata Cv. Tainung No. 2). J Agric Food Chem. 55: 7350-58. http://dx.doi.org/10.1021/jf0711690 Christoph Fiehn. 2009. The future of folic acid antagonist therapy in rheumatoid arthritis. Arthritis & Rheumatism, 60(1): pp 1–4. DOI 10.1002/art.24216 Cho, Y. G., M. L. Cho, S. Y. Min, and H. Y. Kim. 2007. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev. 7: 65-70. http://dx.doi.org/10.1016/j.autrev.2007.08.001 Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 283: 666-8. Crofford, L. J. 2013. Use of NSAIDs in treating patients with arthritis, Arthritis Research and Therapy, 15(SUPPL 3). doi: 10.1186/ar4174. Cutolo, M., A. Sulli, S. Capellino, B. Villaggio, P. Montagna, B. Seriolo, and R. H. Straub. 2004. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 13: 635-8. http://dx.doi.org/10.1191/0961203304lu1094oa Cutolo, M. 2016. Glucocorticoids and chronotherapy in rheumatoid arthritis. Rheumatic & Musculosketal Diseases. doi: 10.1136/rmdopen-2015-000203 Das, S., and P. Padhan. 2017. An overview of the extraarticular involvement in rheumatoid arthritis and its management. J. Pharmacol. Pharmacother. 8:81–86. https:// doi .org/ 10 .4103/ jpp .JPP_194 _16. Di Paola, R., and C. Salvatore. 2008. Predictivity and sensitivity of animal models of arthritis. Autoimmun. Rev. 8:73–75. Feldmann M. 2001. Pathogenesis of arthritis: recent research progress. Nature Immunology. 2: 771–773. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Rheumatoid arthritis. Cell. 85: 307-10. Feldmann, M. 2001. Pathogenesis of arthritis: recent research progress. Nat Immunol. 2: 771–773. Firestein, G. S., 2003. Evolving concepts of rheumatoid arthritis. Nature. 423: 356-61. http://dx.doi.org/10.1038/nature01661 Fu, S. L., Y. H. Hsu, P. Y. Lee, W. C. Hou, L. C. Hung, C. H. Lin, C. M. Chen, and Y. J. Huang. 2006. Dioscorin isolated from Dioscorea alata activates TLR4-signaling pathways and induces cytokine expression in macrophages. Biochem Bioph Res Com. 339: 137-44. http://dx.doi.org/10.1016/j.bbrc.2005.11.005 Gilpin, D. A.. 1996. Calculation of a new Meeh constant and experimental determination of burn size. Burns. 22: 607-611. Gingerich, D. A., and C. A. McPhillips. 2005. Analytical approach to determination of safety of milk ingredients from hyperimmunized cows. Regul. Toxicol. Pharmacol. 41:102–112. http:// dx .doi .org/https:// doi .org/ 10 .1016/ j .yrtph .2004 .10 .002. Gonzalez-Gay, M. A., C. Garcia-Porrua, and A. H. Hajeer. 2002. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arth Rheum. 31: 355-60. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arth Rheum. 30: 1205-13. Grumstrup-Scott. 1989. Guidelines for the Use of Adjuvants in Research Special Emphasis on Freund’s Adjuvant,” pp. 1–5. doi: https://oacu.oir.nih.gov/. Herbert, V., and T. S. Kastan. 1994. Alfalfa, vitamin E, and autoimmune disorders. Am J Clin Nutr. 60: 639-40. Hong, Y. H., W. W. Chao, M. L. Chen, and B. F. Lin. 2009. Ethyl acetate extracts of alfalfa (Medicago sativa L.) sprouts Inhibit lipopolysaccharide-induced inflammation in vitro and in vivo. J Biomed Sci. 16: 64. http://dx.doi.org/10.1186/1423-0127-16-64. Hong, Y. H. , C. J. Huang, S. C. Wang, and B. F. Lin. The ethyl acetate extract of Alfalfa sprouts ameliorates autoimmune-prone disease of MRL-lpr/lpr mice. Lupus. 18: 206-15. http://dx.doi.org/10.1177/0961203308095450. Kai, H., K. Shibuya, Y. Wang, H. Kameta, T. Kameyama, S. Tahara-Hanaoka, A. Miyamoto, S. Honda, I. Matsumoto, A. Koyama, T. Sumida, and A. Shibuya. 2006. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology. 118: 233-9. http://dx.doi.org/10.1111/j.1365-2567.2006.02361.x Kelchtermans, H., S. Struyf, B. De Klerck, et al. 2007. Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacterial-induced granulocyte chemotactic protein-2 production. J Leuk Biol. 81: 1044-53. Kim, M. J., H. N. Kim, K. S. Kang, N. I. Baek, D. K. Kim, Y. S. Kim, B. H. Jeon, and S. H. Kim. 2004. Methanol extract of Dioscoreae Rhizoma inhibits pro-inflammatory cytokines and mediators in the synoviocytes of rheumatoid arthritis. Inter Immunopharm. 4: 1489-97. http:// dx.doi.org/10.1016/j.intimp.2004.07.001 Kim, M. J., Jung, U. S., Jeon, S. W., Lee, J. S., Kim, W. S., Lee, S. B. Y., Kim, C., Kim, B. Y., Wang, T., and Lee, H. G. 2016. Improvement of milk fatty acid composition for production of functional milk by dietary phytoncide oil extracted from discarded pine nut cones in Holstein dairy cows. Asian-Australas. J. Anim. Sci. 29:1734–1741. Klareskog, L., L. Padyukov, and L. Alfredsson. 2007. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol. 19:49-54. http://dx.doi.org/10.1097/BOR.0b013e32801127c8 Khachigian, L. M.. 2006. Collagen antibody-induced arthritis. Nature Protocols. 1:2512-6. Kobayashi, T., T. Ohmori , M. Yanai., G Kawanishi, Y. Yoshikai, and K. Nomoto. 1991. Protective Effect of Orally Administering Immune Milk on Endogenous Infection in X-Irradiated mice. Agric. Biol. Chen. 55(9):2265-2272. Kwon, H. M., Y. J. Choi, J. S. Choi, S. W. Kang, J. Y. Bae, I. J. Kang, J. G. Jun, S. S. Lee, S. S. Lim, and Y. H. Kang. 2007. Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-κB signal disruption. Exp Biol Medi. 232: 235-45. Lin, J. Y., S. Lu, Y. L. Liou, and H. L. Liou. 2006. Increased IgA and IgG serum levels using a novel yam-boxthorn noodle in a BALB/c mouse model. Food Chem Toxicol. 44: 170-8. Li, H., X. Gong, L. Zhang, Z. Zhang, F. Luo, Q. Zhou, J. Chen, and J. Wan. 2009. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice. Phytomed. 16: 538-46. http://dx.doi.org/10.1016/j.phymed.2008.11.002 Lo, M. S. et al. (2013) “Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease : a retrospective cohort study,” Pediatric Rheumatology. Pediatric Rheumatology, 11(1), p. 1. doi: 10.1186/1546-0096-11-42. Lordan, R., and I. Zabetakis. 2017. Invited review: The anti-inflammatory properties of dairy lipids. J. Dairy Sci. 100:4197–4212. Ma, Y., and R. M. Pope. 2005. The role of macrophages in rheumatoid arthritis. Curr Pharm Design. 11: 569-80. Malinow MR, McLaughlin P, Stafford C, Livingston AL, Kohler GO. Alfalfa saponins and alfalfa seeds. Dietary effects in cholesterol-fed rabbits. Atherosclerosis 1980;37: 433-438. Malinow, M. R., E. J. Bardana Jr, B. Pirofsky, S. Craig, and P. McLaughlin. 1982. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science.216: 415-7. Manoury-Schwartz, B., G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, S. Muller, S. Huang, M. C. Boissier, and C. Fournier. 1997. High susceptibility to collagen-induced arthritis in mice lacking IFNgamma receptors. J Immunol. 158: 5501-6. Mauri, C., R. O. Williams, M. Walmsley, and M. Feldmann. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol. 26: 1511-8. http://dx.doi.org/10.1002/eji.1830260716 Mańczak, M. and R. Gasik. 2017. Cervical spine instability in the course of rheumatoid arthritis–imaging methods. Reumatologia 55:201-207. https:// doi .org/ 10 .5114/ reum .2017 .69782. McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Rev Immunol. 7: 429-442. http://dx.doi.org/ 10.1038/nri2094 Medicine Net. 2010. https://www.pinterest.com/pin/321514860891741647/ Murphy, C., C. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 198: 1951-7. http://dx.doi.org/10.1084/jem. 20030896 Nandakumar, K. S., and R. Holmdahl. 2006. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arth Res Ther. 8: 223. http://dx.doi.org/10.1186/ar2089 Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J. F. Bazan, and R. A. Kastelein. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13, 715-25. Ormrod, D.J. and T.E.Miller. 1991. The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmuned cows. Agents Actions. 32:160-166. Owens , W. E. and S. C. Nickerson. 1989. Evaluation of an anti-inflammatory factor derived from hyperimmunized cows. Exp Biol Med. 190(1):79-86. Ormrod, D.J. and T.E.Miller. 1992. A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil. Agents Actions. 37(1-2):70-9. Ormrod, D.J. and T.E. Miller. 1993. Milk from hyperimmunized dairy cows as a source of a novel biological response modifier. Agents Actions. 38:146-9. Owens , W.E., S.C. Nickerson.and P.J.Washburn. 1992. Effect of a milk-derived factor on the inflammatory response to Staphylococcus aureus intramammary infection. Vet Immunol Immunopathol. 30(2-3):233-246. Paola, R. D., and S. Cuzzocrea. 2008. Predictivity and sensitivity of animal models of arthritis. Autoimmun Rev. 8: 73-5. http://dx.doi.org/ 10.1016/j.autrev.2008.07.029 Park, J. H., J. M. Lee, S. N. Kim, S. H. Lee, S. H. Jun, J. H. You, K. S. Ahn, and H. Kang. 2008. Treatment with SI000413, a new herbal formula, ameliorates murine collagen-induced arthritis. Biol. Pharm.Bull. 31: 1337-1342 Pelus, L. M., and H. R. Strausser. 1976. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int. J. Cancer. 18: 653-60 Podolin, P. L., B. J. Bolognese, D. C. Carpenter, T. G. Davis, R. A. Johanson, J. H. Fox, E. Long 3rd, X. Dong, R. W. Marquis, S. M. Locastro, G. J. Terfloth, E. Kurali, J. J. Peterson, B. R. Smith, M. S. McQueney, D. S. Yamashita, and E. A. Capper-Spudich. 2008. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease. J Immunol. 180: 7989-8003. Ponnappan, S. andPonnappan, U. (2011) “Aging and Immune Function: Molecular Mechanisms to Interventions,” Antioxidants & Redox Signaling, 14(8), pp. 1551–1585. doi: 10.1089/ars.2010.3228. Quiring, D. P.. 1955. Surface area determination. Medical Physics.1:1490-94. Rachoń, D., G. Rimoldi, and W. Wuttke. 2006. In vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes. Phytomed. 13: 419-24. http://dx.doi.org/10.1016/j.phymed.2005.10.006 Roberts, J. L., and J. A. Hayashi. 1983. Exacerbation of SLE associated with alfalfa ingestion. N Engl J Med. 308: 1361. Ruffing V., and C. O. Bingham III. 2017. Rheumatoid arthritis signs and symptoms. Accessed June 2017. https:// www .hopkinsarthritis.org/ arthritis -info/ rheumatoid -arthritis/ ra -symptoms/ Schoenroth, L. J. , D. A. Hart, K. M. Pollard, M. J. Fritzler. 2004. The effect of the phytoestrogen coumestrol on the NZB/W F1 murine model of systemic lupus. J Autoimmun. 23: 323-32. http://dx.doi.org/10.1016/j.jaut.2004.09.004 Schulze-Koops, H., and J. R. Kalden. 2001. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 15:677-91. http://dx.doi.org/10.1053/berh.2001.0187 Silman, A. J.; Hochberg, M. C. Epidemiology of the rheumatic diseases. 2001 No.Ed. 2 Scott, D. L., Wolfe, F. andHuizinga, T. W. J. 2010. Rheumatoid arthritis. The Lancet. Elsevier, pp. 1094–1108. doi: 10.1016/S0140-6736(10)60826-4. Simon, G. H., H. E. Daldrup-Link, and E. J. Rummeny. 2007. Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis. Der Radiol. 47: 43-52. Spector, T. D.. 1990. Rheumatoid arthritis. Rheum Dis Clinics North America. 16: 513-37. Stelwagen, K., E. Carpenter, B. Haigh, A. Hodgkinson, and T. T. Wheeler. 2009. Immune components of bovine colostrum and milk. J. Anim. Sci. 87:3–9. https:// doi .org/ 10 .2527/ jas .2008 -1377. Story, J. A., S. L. LePage, M. S. Petro, L. G. West, M. M. Cassidy, F. G. Lightfoot, and G. V. Vahouny. 1984. Interactions of alfalfa plant and sprout saponins with cholesterol in vitro and in cholesterol-fed rats. Am J Clin Nutr. 39: 917-29. Taketa, T., A. Sakai, S. Tanaka, K. Nakai, K. Menuki, H. Yamane, K. Tanaka, and T. Nakamura. 2008. Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells. J Bone Miner Metab. 26: 143-51. http://dx.doi.org/10.1007/s00774-007-0808-2 Terato, K., D. S. Harper, M. M. Griffiths, D. L. Hasty, X. J. Ye, M. A. Cremer, and J. M. Seyer. 1995. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity. 22: 137-47. Thomas, R. Bello and M. A. Tammy. 2005. The use of MicroLactin for inflammatory conditions in equine veterinary practice. J Equine Vet Sci. 25(9)380-382. Trentham, D. E. , A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 146: 857-68. Vermeire, K., H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys. 1997. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 158: 5507-13. Waaler, E.. 2007. On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 115: 422-39. Wagner, S., J. Bindler, and E. Andriambeloson. 2008. Animal models of collagen-induced arthritis. Curr Prot Pharmacol. 5.51.1-5.51.8. Whittam, J., C. Jensen, and T. Hudson. 1995. Alfalfa, vitamin E, and autoimmune disorders. Am J Clin Nutr. 62:1025-26. Wong, W. L., X. Su, X. Li, C. M. Cheung, R. Klein, C. Y. Cheng, and T. Y. Wong. 2014. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2:e106–e116. https:// doi .org/ 10 .1016/ S2214 -109X(13)70145 -1. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 154: 688-700. Wu K. , Cho ML, Jung YO, Min SY, Park SW, Min DJ, Yoon JH, Kim HY. 2004. Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci. 327(4):202-11. Yinshi Yue; Y. Yu, Y. Yue, Z. Zhang, and K. Su. 2013. Microbial infection and rheumatoid arthritis. J Clin Cell Immunol. 4(6):174.doi: 10.4172/2155-9899.1000174 Zenk, J. L., T. R. Helmer, and M. A. Kuskowski. 2002. The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: An exploratory, randomized, double-blind, placebo-controlled trial. Curr. Therapeutic Res. 63:430–442. https://doi .org/10 .1016/ S0011-393X(02)80049-2. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71998 | - |
dc.description.abstract | 伴隨醫療科技日益進步及人民平均餘命延長,人口結構老化造成已成世界趨勢,退化性疾病成為亟需重視並應尋求預防的問題。越來越多研究指出有些慢性疾病可藉由生活習慣的改善而略為緩解。關節炎 (arthritis) 為人類疾病中最普遍的慢性關節疾病,而類風濕性關節炎是屬於自體免疫異常的一種關節炎,可能造成嚴重時的生理機能不正常。本研究在於探討建立預防或舒緩關節症狀保健功能之評估方法,研究方法包括蒐集現今可有效誘發關節炎的實驗動物模式及不同品系鼠種的誘發關節炎成效,找出適當的誘發關節炎的動物實驗模式,接著餵食本實驗室之前以體外實驗篩選出來具抗發炎潛力的食材苜蓿芽,進一步用以評估其他具免疫調節保健功效的食品。
本研究誘發關節炎的動物模式,是以致病機制及病程和人類的類風溼性關節炎致病模式較相似的膠原蛋白誘發關節炎(collagen induced arthritis,簡稱CIA)動物模式,免疫接種較具誘發成效的DBA/1J小鼠,再以苜宿芽餵食被誘發關節炎的小鼠,測相關生化與免疫指標。本研究以DBA/1J小鼠誘發類風濕性關節炎的成功率為85%,但評估經CIA的故以DBA/1J小鼠的CIA模式,於發炎高峰期(免疫接種七週)後分組管餵具抗發炎效果的苜蓿芽乙酸乙脂萃物 (ASEA) 測試,結果在藥物組亦未顯示有良好的舒緩類風濕性關節炎成效,經調整研究設計,於免疫接種的隔日即進行分組及管餵投予測試食材,餵食ASEA及市售免疫奶粉評估其抗發炎成效,結果顯示餵食ASEA及免疫奶粉,可降低小鼠發炎指標,包括:降低小鼠四肢的發炎腫脹指數;顯著降低血清中的抗體濃度,包括特異性抗體IgG2a濃度及發炎性抗體總 IgG濃度;降低Th1反應之發炎性細胞激素TNF-α、IFN-γ、IL-2及IL-1β的分泌量;降低調節Th1反應的IL-12 細胞激素分泌量。 綜合上述實驗結果可知,本研究以CIA模式免疫接種DBA/1J小鼠七週,並於免疫接種的一開始餵食保健食品的動物實驗模式,適合作為評估保健食材舒緩類風溼性關節炎的保健功效,且顯示本次研究的苜蓿芽乙酸乙酯萃取物及免疫奶粉在早期餵食的CIA誘發動物模式下,具有調節發炎性細胞指標T細胞,降低Th1反應,抑制促發炎細胞激素的分泌,降低發炎反應,進而達到舒緩類風濕性關節炎的功效。 | zh_TW |
dc.description.abstract | Population aging is a world-wide tendency as for the great progress of medicine and extend of life expectancy. Degeneration disease should be gotten more attention and seek for solution and prevention urgently. There are more evidences show that chronic diseases can be alleviated by healthy diet pattern and life style. Arthritis is the common chronic disease in elderly. Rheumatoid arthritis which resulting from an overactive immune system is belonging to autoimmune disease and will cause serious disease. The purpose of this study is to focus on the anti-rheumatoid arthritic effect of functional food.
In the study, we chose CIA (collagen induced arthritis) as animal model because it possesses many similarities to human RA. The CIA model immunization DBA/1J mice and then fed heathy food to evaluation the anti-rheumatoid arthritis effects. The efficiency of arthritis induction was 85% in CIA-DBA/1J mice. At first exam, the result didn’t show good anti-inflammation ability even in drug group. So we adjust feeding time immediate from the day after immunization. We found ASEA and hyperimmune milk show good anti-inflammation ability by decreasing total swelling score and decreasing the level of specific antibody IgG2a, inflammation antibody IgG and inflammation cytokine such as TNF-α、IFN-γ、IL-2 and IL-12. As a conclusion, we successfully evaluation of the healthy food with anti-rheumatoid arthritis effects by CIA_DBA/1J animal model and found that administration of ASEA or hyperimmune milk during the early stages of CIA development resulting in a modulating effect on inflammation markers and on the progress of symptoms of arthritis in animal, decrease Th1 reaction, inhibit secrete of inflammation cytokine and alleviate rheumatoid arthritis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T06:18:25Z (GMT). No. of bitstreams: 1 ntu-107-D96641008-1.pdf: 4268368 bytes, checksum: 46e06c30a2bbd97767886e652974bd2a (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 目 錄
口試委員會審定書……………………………………………………………………………………………………… i 誌謝…………………………………………………………………………………………………………………………………… ii 中文摘要………………………………………………………………………………………………………………………… iii 英文摘要…………………………………………………………………………………………………………………………… v 目錄……………………………………………………………………………………………………………………………………… vi 圖目錄………………………………………………………………………………………………………………………………… ix 表目錄………………………………………………………………………………………………………………………………… x 第 一 章 文 獻 回 顧……………………………………………………………………………………………… 1 第一節 類風濕性關節炎………………………………………………………………………………………… 1 一. 免疫反應………………………………………………………………………………………………………… 1 二. 關節炎簡介…………………………………………………………………………………………………… 2 三. 類風濕性關節炎簡介……………………………………………………………………………… 2 1.致病原因…………………………………………………………………………………………………… 4 2.盛行率………………………………………………………………………………………………………… 9 3.類風濕性關節炎的臨床症狀及檢測……………………………………………… 9 4.類風濕性關節炎的治療……………………………………………………………………… 11 第二節 類風濕性關節炎的致病動物模式………………………………………………………… 12 一. 抗原誘發模式……………………………………………………………………………………………… 12 二. 抗體誘發模式……………………………………………………………………………………………… 13 三. 其他致病模式……………………………………………………………………………………………… 13 第三節 保健食材苜蓿芽的舒緩類風性關節炎功效…………………………… 14 第四節 保健食材免疫奶粉的免疫調節功效………………………………………………… 15 第五節 抗類風濕性關節炎的實驗組藥物:Indomethacin……………………… 16 第 二 章 苜蓿芽舒緩類風濕性關節炎的功效評估………………………………………… 18 第一節 前言……………………………………………………………………………………………………………… 18 第二節 實驗設計………………………………………………………………………………………………………… 18 第三節 實驗材料與方法…………………………………………………………………………………… 19 一. 實驗動物………………………………………………………………………………………………………… 19 二. CIA誘發關節炎小鼠之尾皮下注射操作…………………………………………… 20 三. 管餵樣品製備……………………………………………………………………………………………… 21 四. 生化試劑………………………………………………………………………………………………………… 22 五. 實驗檢測方法……………………………………………………………………………………………… 23 1.血液樣品之採集與處理……………………………………………………………………… 23 2.腹腔細胞之採集與培養……………………………………………………………………… 24 3.脾臟細胞之採集及培養……………………………………………………………………… 24 4.細胞激素含量測定……………………………………………………………………………… 25 5.關節炎小鼠四肢腫脹計分方法…………………………………………………… 26 六. 統計方法………………………………………………………………………………………………………… 26 第四節 CIA誘發成功後餵食ASEA的成效評估……………………………………………… 26 一. CIA誘發類風溼性關節炎流程……………………………………………………………… 26 二. 實驗結果………………………………………………………………………………………………………… 27 第五節 討論……………………………………………………………………………………………………………… 34 一. 關節炎動物模式鼠種之選擇………………………………………………………………… 34 二. 精確定量誘發物以達良好的誘發效果………………………………… 35 三. 關節炎小鼠四肢腫脹分數以評估發炎程度指標的客觀性……… 36 四. 研究觀察時程……………………………………………………………………………………… 37 五. 苜蓿芽對發炎過程分泌促發炎激素的影響…………………………………… 37 六. RA高峰期後餵食抗發炎性保健食材的功效評估………………………… 38 . 第 三 章 評估免疫奶粉舒緩類風濕性關節炎的功效…………………………………… 39 第一節 前言……………………………………………………………………………………………………………………39 第二節 實驗設計………………………………………………………………………………………………………… 40 第三節 實驗材料與方法……………………………………………………………………………………………40 一 類風濕性關節炎的動物模式……………………………………………………………………40 1. 實驗動物………………………………………………………………………………………………………… 40 2. 誘發類風濕性關節炎材料…………………………………………………………………… 41 3. 誘發方法………………………………………………………………………………………………………… 41 二. 管餵樣品……………………………………………………………………………………………………… 42 三. 分析樣品收集……………………………………………………………………………………………… 44 四. 統計方法………………………………………………………………………………………………………… 45 第四節 結果………………………………………………………………………………………………………………… 45 第五節 討論……………………………………………………………………………………………………………… 60 第 四 章 綜合討論及總結………………………………………………………………………………………… 62 第 五 章 參考文獻………………………………………………………………………………………………………… 63 附 錄 ……………………………………………………………………………………………………… 79 | |
dc.language.iso | zh-TW | |
dc.title | 舒緩類風濕性關節炎的保健食品功效評估 | zh_TW |
dc.title | Evaluation of the healthy food with anti-rheumatoid arthritis effects | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 林璧鳳(Bi-Fong Lin) | |
dc.contributor.oralexamcommittee | 江伯倫(Bor-Luen Chiang),龔瑞林(Zwe-Ling Kong),洪永瀚(Yong-Han Hung) | |
dc.subject.keyword | 類風溼性關節炎,自體免疫,DBA/1J小鼠,抗膠原蛋白抗體,免疫奶粉, | zh_TW |
dc.subject.keyword | rheumatoid arthritis,autoimmune disease,DBA/1J mice,anti-collagen antibody,hyperimmune milk, | en |
dc.relation.page | 89 | |
dc.identifier.doi | 10.6342/NTU201803993 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-20 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 4.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。